Enzymit is developing a computational design platform to engineer "new-to-nature" enzymes for enzymatic manufacturing. The company uses these designer enzymes in a cell-free production process to avoid cellular fermentation issues such as toxicity, side products, sub-optimal enzyme ratios, and varying temperature optima. Enzymit's platform aims to replace inefficient and polluting chemical reactions and enable manufacture of complex molecules and materials that are otherwise impossible. With the new $5 million seed financing, Enzymit plans to accelerate development of its computational tools and expand its product pipeline, including a novel enzymatic process to convert atmospheric carbon into bio-polymers. The article frames this effort against the $100 billion biomanufacturing industry and the $4 trillion global chemical industry that Enzymit targets to disrupt. CEO and co-founder Dr. Gideon Lapidoth said the company aims to solve the enzyme bottleneck limiting biomanufacturing.

Total raised

$5M

Funding rounds

1

Latest round

Seed

Latest activity

Apr 2022